Position in PBYI
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$338,900
+$18,225 QoQ
Shares Held
53,036
-1.6% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,189,862,767 across 287 Biotechnology names. PBYI ranks #171 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in PBYI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $338,900 | 53,036 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $320,675 | 53,895 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $318,605 | 60,001 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $207,895 | 60,611 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $113,353 | 38,295 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $116,787 | 38,291 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $118,901 | 46,628 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $163,880 | 50,270 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $11,055 | 2,086 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,032 | 2,086 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $5,486 | 2,086 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $7,363 | 2,086 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $111,672 | 38,775 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $117,863 | 38,771 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $277,659 | 39,609 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $358,396 | 39,041 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $403,273 | 41,489 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $464,459 | 45,269 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $423,870 | 42,009 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $511,810 | 49,071 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $352,547 | 41,771 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||